The Cooper Companies, Inc. $COO Holdings Decreased by Swedbank AB

Swedbank AB reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 24.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 904,029 shares of the medical device company’s stock after selling 284,744 shares during the quarter. Swedbank AB’s holdings in Cooper Companies were worth $61,980,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. raised its holdings in shares of Cooper Companies by 0.9% during the first quarter. American Century Companies Inc. now owns 45,616 shares of the medical device company’s stock worth $3,848,000 after purchasing an additional 406 shares during the period. FORA Capital LLC bought a new stake in shares of Cooper Companies during the 1st quarter valued at about $984,000. Champlain Investment Partners LLC raised its stake in Cooper Companies by 1.8% during the first quarter. Champlain Investment Partners LLC now owns 1,767,015 shares of the medical device company’s stock worth $149,048,000 after acquiring an additional 30,775 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in Cooper Companies during the first quarter worth about $850,000. Finally, GKV Capital Management Co. Inc. bought a new position in Cooper Companies in the first quarter worth about $40,000. 24.39% of the stock is currently owned by institutional investors.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Experienced board addition — CooperCompanies appointed Walter M. Rosebrough Jr., former STERIS CEO, as an independent director effective Jan. 3, 2026. His track record in medical devices and the Board’s pledge to consider him for Chair by end?2026 are being viewed as a credibility and governance upgrade that could support strategic execution. CooperCompanies Appoints Walter M Rosebrough, Jr to its Board of Directors
• Positive Sentiment: Insider buying — Director Cynthia L. Lucchese bought 1,784 shares at ~$84.06 on Dec. 22, increasing her stake ~23%. Recent insider purchases are often read as confidence signals and can support sentiment while the market evaluates governance changes. SEC Filing — Insider Purchase
• Neutral Sentiment: Cooperation agreement and filings — The Company entered a cooperation agreement with Browning West, which includes standstill/voting commitments and an 8?K disclosure. These formalize the arrangement but don’t immediately change fundamentals; investors should read the filed agreement for specifics on governance and timing. Press Release / 8?K Disclosure
• Neutral Sentiment: Short?interest data appears unreliable — a December entry shows “0 shares” and NaN changes; treat that as a data anomaly rather than a market signal until exchanges/feeds correct the figure.
• Negative Sentiment: Activist/uncertainty risk — Browning West’s involvement signals prior shareholder dissatisfaction. While cooperative now, the process of board refresh, potential shifts in capital allocation or strategic priorities, and transition risk can create short?term volatility until execution clarity arrives. Quiver Quant — Cooperation Agreement Summary

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on COO shares. Piper Sandler reiterated an “overweight” rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Stifel Nicolaus set a $95.00 price objective on Cooper Companies and gave the stock a “buy” rating in a research note on Friday, December 5th. Needham & Company LLC reiterated a “buy” rating and issued a $100.00 target price (up from $94.00) on shares of Cooper Companies in a research note on Friday, December 5th. Weiss Ratings restated a “sell (d+)” rating on shares of Cooper Companies in a research report on Monday. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and issued a $71.00 price objective (up previously from $64.00) on shares of Cooper Companies in a report on Monday, December 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $90.15.

Insider Transactions at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III purchased 10,000 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was bought at an average cost of $80.80 per share, with a total value of $808,000.00. Following the acquisition, the chief executive officer owned 236,151 shares of the company’s stock, valued at $19,081,000.80. The trade was a 4.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Maria Rivas bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was acquired at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the acquisition, the director directly owned 11,141 shares in the company, valued at approximately $915,010.33. This represents a 9.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 18,014 shares of company stock valued at $1,441,196 in the last quarter. 1.98% of the stock is owned by company insiders.

Cooper Companies Stock Performance

Shares of COO opened at $82.32 on Thursday. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $100.24. The firm has a market capitalization of $16.13 billion, a PE ratio of 43.79, a P/E/G ratio of 2.36 and a beta of 1.05. The firm has a 50-day moving average price of $75.49 and a 200 day moving average price of $72.30. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has authorized a share buyback program on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s management believes its stock is undervalued.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.